Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to -$777966.0.

  • KORU Medical Systems' Net Income towards Common Stockholders rose 5078.71% to -$777966.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.7 million, marking a year-over-year increase of 6901.55%. This contributed to the annual value of -$6.1 million for FY2024, which is 5585.03% up from last year.
  • Latest data reveals that KORU Medical Systems reported Net Income towards Common Stockholders of -$777966.0 as of Q3 2025, which was up 5078.71% from -$206867.0 recorded in Q2 2025.
  • In the past 5 years, KORU Medical Systems' Net Income towards Common Stockholders registered a high of -$206867.0 during Q2 2025, and its lowest value of -$7.5 million during Q4 2023.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$1.4 million (2023), whereas its average is -$1.9 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 53895.98% in 2021, then skyrocketed by 7912.88% in 2024.
  • Over the past 5 years, KORU Medical Systems' Net Income towards Common Stockholders (Quarter) stood at -$1.1 million in 2021, then plummeted by 85.02% to -$2.0 million in 2022, then plummeted by 277.7% to -$7.5 million in 2023, then surged by 79.13% to -$1.6 million in 2024, then surged by 50.07% to -$777966.0 in 2025.
  • Its Net Income towards Common Stockholders stands at -$777966.0 for Q3 2025, versus -$206867.0 for Q2 2025 and -$1.2 million for Q1 2025.